Fleseriu, M., Langlois, F., Lim, D. S. T., Varlamov, E. V. & Melmed, S. Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol. 10, 804–826 (2022).

Article  CAS  PubMed  Google Scholar 

Colao, A. et al. Acromegaly. Nat. Rev. Dis. Prim. 5, 20 (2019).

Article  PubMed  Google Scholar 

Gadelha, M. R., Kasuki, L., Lim, D. S. T. & Fleseriu, M. Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr. Rev. 40, 268–332 (2019).

Article  PubMed  Google Scholar 

Pivonello, R. et al. Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20, 46–62 (2017).

Article  PubMed  Google Scholar 

Esposito, D. et al. Effect of diabetes on morbidity and mortality in patients with acromegaly. J. Clin. Endocrinol. Metab. 107, 2483–2492 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Moller, N. & Jorgensen, J. O. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30, 152–177 (2009).

Article  PubMed  Google Scholar 

Freda, P. U. et al. Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly. J. Clin. Endocrinol. Metab. 93, 2334–2343 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moller, N. et al. Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J. Clin. Endocrinol. Metab. 74, 1012–1019 (1992).

CAS  PubMed  Google Scholar 

Nielsen, S., Moller, N., Christiansen, J. S. & Jorgensen, J. O. Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes 50, 2301–2308 (2001).

Article  CAS  PubMed  Google Scholar 

Hjelholt, A. J. et al. Insulin resistance induced by growth hormone is linked to lipolysis and associated with suppressed pyruvate dehydrogenase activity in skeletal muscle: a 2 x 2 factorial, randomised, crossover study in human individuals. Diabetologia 63, 2641–2653 (2020).

Article  CAS  PubMed  Google Scholar 

Zierler, K. L. & Rabinowitz, D. Roles of insulin and growth hormone, based on studies of forearm metabolism in man. Medicine 42, 385–402 (1963).

Article  CAS  PubMed  Google Scholar 

Roden, M. et al. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 97, 2859–2865 (1996).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Randle, P. J., Garland, P. B., Hales, C. N. & Newsholme, E. A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785–789 (1963).

Article  CAS  PubMed  Google Scholar 

Nellemann, B. et al. Growth hormone-induced insulin resistance in human subjects involves reduced pyruvate dehydrogenase activity. Acta Physiol. 210, 392–402 (2014).

Article  CAS  Google Scholar 

del Rincon, J. P. et al. Growth hormone regulation of p85α expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes 56, 1638–1646 (2007).

Article  PubMed  Google Scholar 

Barbour, L. A. et al. Increased P85α is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J. Biol. Chem. 280, 37489–37494 (2005).

Article  CAS  PubMed  Google Scholar 

Nielsen, C. et al. Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade. J. Clin. Endocrinol. Metab. 93, 2842–2850 (2008).

Article  CAS  PubMed  Google Scholar 

Jessen, N. et al. Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion. Am. J. Physiol. Endocrinol. Metab. 288, E194–199 (2005).

Article  CAS  PubMed  Google Scholar 

Arlien-Soborg, M. C. et al. Reversible insulin resistance in muscle and fat unrelated to the metabolic syndrome in patients with acromegaly. EBioMedicine 75, 103763 (2022).

Article  PubMed  Google Scholar 

Chen, J. W. et al. A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am. J. Physiol. Endocrinol. Metab. 284, E1149–1155 (2003).

Article  CAS  PubMed  Google Scholar 

Vila, G., Jorgensen, J. O. L., Luger, A. & Stalla, G. K. Insulin resistance in patients with acromegaly. Front. Endocrinol. 10, 509 (2019).

Article  Google Scholar 

Alexopoulou, O. et al. Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients. Pituitary 17, 81–89 (2014).

Article  CAS  PubMed  Google Scholar 

Dal, J. et al. Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur. J. Endocrinol. 175, 181–190 (2016).

Article  CAS  PubMed  Google Scholar 

Petrossians, P. et al. Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) Database. Endocr. Relat. Cancer 24, 505–518 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Slagboom, T. N. A., van Bunderen, C. C., De Vries, R., Bisschop, P. H. & Drent, M. L. Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines. Pituitary 26, 319–332 (2023).

Article  PubMed  PubMed Central  Google Scholar 

González, B., Vargas, G., de Los Monteros, A. L. E., Mendoza, V. & Mercado, M. Persistence of diabetes and hypertension after multimodal treatment of acromegaly. J. Clin. Endocrinol. Metab. 103, 2369–2375 (2018).

Article  PubMed  Google Scholar 

Esposito, D., Ragnarsson, O., Johannsson, G. & Olsson, D. S. Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur. J. Endocrinol. 182, 523–531 (2020).

Article  CAS  PubMed  Google Scholar 

Lenders, N. F., McCormack, A. I. & Ho, K. K. Y. Management of endocrine disease: does gender matter in the management of acromegaly? Eur. J. Endocrinol. 182, R67–R82 (2020).

Article  CAS  PubMed  Google Scholar 

Holdaway, I. M., Bolland, M. J. & Gamble, G. D. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur. J. Endocrinol. 159, 89–95 (2008).

Article  CAS  PubMed  Google Scholar 

Esposito, D. et al. Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study. Eur. J. Endocrinol. 178, 459–469 (2018).

Article  CAS  PubMed  Google Scholar 

Arnardottir, S. et al. Long-term outcomes of patients with acromegaly: a report from the Swedish Pituitary Register. Eur. J. Endocrinol. 186, 329–339 (2022).

Article  CAS  PubMed  Google Scholar 

Bolfi, F., Neves, A. F., Boguszewski, C. L. & Nunes-Nogueira, V. S. Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis. Eur. J. Endocrinol. 179, 59–71 (2018).

Article  CAS  PubMed